chartexchange

QURE
uniQure N.V.
stockNASDAQ

At CloseNov 6, 2026 3:59:54 PM EST
21.69USD+3.237%(+0.68)1,172,907
Pre-marketNov 6, 2026 9:27:30 AM EST
21.21USD+0.952%(+0.20)
After-hoursNov 6, 2026 4:57:30 PM EST
20.83USD-3.947%(-0.86)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Amsterdam, Netherlands
Previous Close
$21.01
Beta
0.58
52-Week High
$51.72 2026-08-25
52-Week Low
$8.73 2026-03-03
SMA 50
$31.86
SMA 200
$29.66
Avg. Vol 10D
2.46M
Avg. Vol 30D
3.23M
Avg. Vol 90D
1.98M
Relative Vol
0.36
57.52M
0.2600%
2,500,000
14,116
QURE Profile

uniqure is delivering on the promise of gene therapy - single treatments with potentially curative results. we are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.

QURE Performance
PeriodPriceDateChangeBeta
1W22.972026-11-02-5.53%1.525
1M22.592026-10-09-3.94%1.824
3M46.062026-08-10-52.89%1.563
6M27.662026-05-08-21.55%-0.285
1Y26.152025-11-10-17.02%0.583
2Y7.792024-11-08+178.56%—
5Y34.572021-11-09-37.23%1.294
QURE Stock Summary

uniQure N.V. (NASDAQ:QURE) stock price today is $21.70, and today's volume is 1,172,907. QURE is up 3.284% today. The 30 day average volume is 3.23M. QURE market cap is $1.52B with 70.14M shares outstanding.